Published: 2 March 2017
Prescriber Update 38(1): 4
The use of tramadol in children was discussed by the Medicines Adverse Reactions Committee (MARC) in 2016 (www.medsafe.govt.nz/profs/adverse/Minutes166.htm#3.2.3).
Tramadol is indicated for the relief of moderate to severe pain in adults and children. Most of the studies conducted in children investigated the use of tramadol in postoperative pain. The MARC considered that there is a role for the use of tramadol in children. However, as there is very limited data on the efficacy and safety in younger children, the MARC recommended that tramadol should be contraindicated in children aged two years and under. The tramadol data sheets are in the process of being updated with this contraindication as well as additional information on use following tonsillectomy, adenoidectomy or throat surgery.
Further information on the use of tramadol is available at www.medsafe.govt.nz/profs/PUArticles/December2014Tramadol.htm.
PHARMAC has released its decision on the funding of tramadol oral drops in Section H of the Pharmaceutical Schedule (hospital pharmaceuticals). The decision is to:
Please take care when prescribing, dispensing and administering tramadol oral drops during this transition period to ensure the correct dose is given to the patient.
Further information on this change in funding is available on the PHARMAC website (www.pharmac.govt.nz/news/notification-2016-12-13-tramadol-hydrochloride/).